Showing results (991-1000 of 1,101) with videos related to

Sort By:
Pageof 111
Journal of Cellular and Molecular Medicine|January 24, 2020
Vitamin B6 inhibits macrophage activation to prevent lipopolysaccharide-induced acute pneumonia in miceMei-Rong Shan, Sheng-Nan Zhou, Chang-Ning Fu, et al.
Medicine|May 27, 2016
Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular CarcinomaTao Zhang, Yu-Ting Zhao, Zhi Wang, et al.
Oncotarget|March 26, 2016
Interim analysis of postoperative chemoradiotherapy with capecitabine and oxaliplatin versus capecitabine alone for pathological stage II and III rectal cancer: a randomized multicenter phase III trialYan-Ru Feng, Yuan Zhu, Lu-Ying Liu, et al.
Leukemia & Lymphoma|November 1, 2011
The extent of cutaneous lesions predicts outcome in extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract with secondary cutaneous involvementShu-Nan Qi, Ye-Xiong Li, Wei-Hu Wang, et al.
The Spine Journal : Official Journal of the North American Spine Society|September 23, 2020
How much space of the spinal canal should be restored by hoisting the vertebrae-OPLL complex for sufficient decompression in anterior controllable antedisplacement and fusion? A multicenter clinical radiological studyChen Yan, Huai-Cheng Jia, Hao-Yuan Tan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 6, 2015
Survival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vesselsWei-Hu Wang, Zhi Wang, Jian-Xiong Wu, et al.
Blood|July 25, 2012
Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapyZhao-Yang Wang, Qing-Feng Liu, Hua Wang, et al.
British Journal of Cancer|March 25, 2023
The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I-III triple-negative breast cancerGuang-Yi Sun, Jing Zhang, Bing-Zhi Wang, et al.
Nature Communications|May 6, 2016
miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpointShaohua Xu, Zhen Tao, Bo Hai, et al.
Frontiers in Immunology|September 7, 2021
Increased Neutrophil Aging Contributes to T Cell Immune Suppression by PD-L1 and Arginase-1 in HIV-1 Treatment Naïve PatientsKai Liu, Hui-Huang Huang, Tao Yang, et al.
Pageof 111